Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.238; its P/E ratio is -6.41; Atossa Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -7.75M	$ -6.23M	$ -9.83M	$ -6.28M	$ -8.37M
EBITDA	$ -7.74M	$ -6.23M	$ -9.83M	$ -6.28M	$ -8.37M
Net Income Common Stockholders	$ -7.76M	$ -6.23M	$ -9.83M	$ 7.92M	$ -7.49M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 88.46M	$ 94.03M	$ 99.50M	$ 103.98M	$ 111.00M
Total Assets	$ 96.25M	$ 101.69M	$ 108.36M	$ 115.46M	$ 123.53M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -88.46M	$ -94.03M	$ -99.50M	$ -103.98M	$ -111.00M
Total Liabilities	$ 5.24M	$ 3.44M	$ 3.48M	$ 2.94M	$ 5.57M
Stockholders Equity	$ 91.02M	$ 98.25M	$ 104.88M	$ 113.26M	$ 117.96M
Cash Flow	-
Free Cash Flow	$ -5.57M	$ -3.88M	$ -4.48M	$ 111.11M	-
Operating Cash Flow	$ -5.57M	$ -3.88M	$ -4.46M	$ 111.11M	-
Investing Cash Flow	-	$ -1.00K	$ -13.00K	-	-
Financing Cash Flow	-	$ -1.48M	-	-	-

Currency in USD

Atossa Therapeutics Earnings and Revenue History

Income Statement >

Atossa Therapeutics Debt to Assets

Balance Sheet >

Atossa Therapeutics Cash Flow

Cash Flow >

Atossa Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing